MYC on the Path to Cancer

Dang, Chi V.·2012·Cell

DOI 10.1016/j.cell.2012.03.003

Cited by (1,008)

Items 801–900 of 1,008

Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway
Xia Liu, Xiangyang Xiao, Qiyang Shou, Junfeng Yan, Long Chen, Huiying Fu, Jianchao Wang · 2016 · Journal of Ethnopharmacology
JQ1, a small molecule inhibitor of BRD4, suppresses cell growth and invasion in oral squamous cell carcinoma
Limei Wang, Xiuyin Wu, Ping Cheong Huang, Zhijun Lv, Yuping Qi, Xiujuan Wei, Pishan Yang, Fenghe Zhang · 2016 · Oncology Reports
The Diverse Consequences of FOXC1 Deregulation in Cancer
Liam Niall Gilding, Tim C. P. Somervaille · 2019 · Cancers
NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer
Alexander J. Cole, Mangala Iyengar, Santiago Panesso-Gómez, Patrick O’Hayer, Daniel Chan, Greg M. Delgoffe, Katherine M. Aird, Euisik Yoon, Shoumei Bai, Ronald J. Buckanovich · 2020 · JCI Insight
Argonaute binding within 3′-untranslated regions poorly predicts gene repression
Yongjun Chu, Audrius Kilikevičius, Jing Liu, Krystal C. Johnson, Shinnichi Yokota, David R. Corey · 2020 · Nucleic Acids Research
Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors
Mihai Ioan Truica, Michael C. Burns, Huiying Han, Sarki Abba Abdulkadir · 2020 · Cancer Research
Malignancy and IFITM3: Friend or Foe?
Ushani Rajapaksa, Jin Chen, Tao Dong · 2020 · Frontiers in Oncology
Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia
Xueliang Gao, Shenghui Qin, Yongxia Wu, Chen Chu, Baishan Jiang, Roger H. Johnson, Dong Kuang, Jie Zhang, Xi Wang, Anand S. Mehta et al. · 2021 · Journal of Clinical Investigation
Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c‑Myc translation
Hua Huang, Huan Li, Ruining Pan, Sijia Wang, Aamir Ali Khan, Yue Zhao, Huiyu Zhu, Xinhui Liu · 2021 · International Journal of Oncology
Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc
Yunhua Peng, Jing Liu, Zhen Wang, Chun‐Ping Cui, Shuangxi Zhang, Shuangxi Zhang, Peipei Gao, Zhanwu Hou, Huadong Liu, Jianping Guo et al. · 2022 · Cell Death and Differentiation
MYC is a critical target of FBXW7
Mai Sato, Ruth Rodriguez Barrueco, Jiyang Yu, Catherine Do, José M. Silva, Jean Gautier · 2014 · Oncotarget
Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells
Jir‐You Wang, Po‐Kuei Wu, Paul Chih-Hsueh Chen, Chia-Wen Lee, Wei‐Ming Chen, Shih‐Chieh Hung · 2016 · Stem Cells Translational Medicine
Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin
Armin Wiegering, Niels Matthes, Bettina Mühling, Monika Koospal, Anne Quenzer, Stephanie Peter, Christoph-Thomas Germer, Michael Linnebacher, Christoph Otto · 2017 · Neoplasia
E-Cadherin/β-Catenin Complex: A Target for Anticancer and Antimetastasis Plants/Plant-derived Compounds
Majid Tafrihi, Roohollah Nakhaei Sistani · 2017 · Nutrition and Cancer
Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells
Saravana Kumar Kailasam Mani, OURANIA M. ANDRISANI · 2018 · Genes
MYC-induced metabolic stress and tumorigenesis
Adam J. Wolpaw, Chi Van Dang · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
Sa Rang Kim, Julia M. Lewis, Benoit M. Cyrenne, Patrick F. Monico, Fatima Nadeem Mirza, Kacie R. Carlson, Francine M. Foss, Michael Girardi · 2018 · Oncotarget
It takes a team: a gain-of-function story of p53-R249S
Huai Wang, Peng Liao, Shelya X. Zeng, Hua Lu · 2019 · Journal of Molecular Cell Biology
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer
Houliang Deng, Xiaowen Guan, Longcai Gong, Jianming Zeng, Hongjie Zhang, Mike Y. Chen, Gang Li · 2019 · Scientific Reports
MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways
Jey Sabith Ebron, Eswar Shankar, Jagjit Singh, Kavleen Sikand, Crystal M. Weyman, Sanjay Gupta, Daniel J. Lindner, Xiaoqi Liu, Moray J. Campbell, Girish C. Shukla · 2019 · Cancer Research
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation
Marion Le Grand, Anna Mukha, Jakob Püschel, Emanuele Valli, Alvin Kamili, Orazio Vittorio, Anna Dubrovska, Maria Kavallaris · 2020 · Theranostics
TFEB Links MYC Signaling to Epigenetic Control of Myeloid Differentiation and Acute Myeloid Leukemia
Seongseok Yun, Nicole D. Vincelette, Xiaoqing Yu, Gregory W. Watson, Mario R. Fernandez, Chunying Yang, Taro Hitosugi, Chia‐Ho Cheng, Audrey R. Freischel, Ling Zhang et al. · 2020 · Blood Cancer Discovery
Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy
Xiao‐Xin Sun, Yanping Li, Rosalie C. Sears, Mu‐Shui Dai · 2021 · Frontiers in Oncology
Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials
Peng Qiu, Shiming Tan, Longzheng Xia, Nayiyuan Wu, Linda Oyang, Yanyan Tang, Min Su, Xia Luo, Ying Wang, Xiaowu Sheng et al. · 2022 · International Journal of Biological Sciences
An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
Xuanyou Liu, Hao Wu, Zhenguo Liu · 2022 · Cancers
Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling
Xianjue Ma, Jing-Yi Huang, Y Tian, Yiliang Chen, Yinke Yang, Xiao Zhang, Fan Zhang, Lei Xue · 2017 · Oncogene
BC200 (BCYRN1) – The shortest, long, non-coding RNA associated with cancer
J. Samson, Sarah Cronin, Kellie A. Dean · 2018 · Non-coding RNA Research
Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy
Man Yu, Ting Liu, Yi-Cheng Chen, Yafang Li, Wenhua Li · 2018 · Journal of Experimental & Clinical Cancer Research
Intricate crosstalk between MYC and non‐coding RNA s regulates hallmarks of cancer
Lotteke J. Y. M. Swier, Agnieszka Dzikiewicz‐Krawczyk, Melanie Winkle, Anke van den Berg, Joost L. Kluiver · 2018 · Molecular Oncology
Metabolic reprogramming in the pathogenesis of glioma: Update
Kenta Masui, Hiromi Onizuka, Webster K. Cavenee, Paul S. Mischel, Noriyuki Shibata · 2019 · Neuropathology
Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation
Jeannine Diesch, Megan J. Bywater, Elaine Sanij, Donald P. Cameron, William S. Schierding, Natalie Brajanovski, Jinbae Son, Jirawas Sornkom, Nadine Hein, M. Evers et al. · 2019 · Communications Biology
c-Myc regulates the CDK1/cyclin B1 dependent‑G2/M cell cycle progression by histone H4 acetylation in Raji cells
Yan Yang, Kai Xue, Zhi Li, Zheng Wei, Weijie Dong, Jiazhe Song, Shijie Sun, Tonghui Ma, Wenzhe Li · 2018 · International Journal of Molecular Medicine
Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy
Mengjie Gu, Tan Boon Toh, Lissa Hooi, Jhin Jieh Lim, Xiyun Zhang, Edward Kai‐Hua Chow · 2019 · ACS Applied Materials & Interfaces
Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3–c-Myc axis
Qingzu Gao, Rui Zhou, Yuan Meng, Rongfei Duan, Ling Wu, Rui Li, Fengliu Deng, Chuang Lin, Liang Zhao · 2020 · Oncogene
Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer
Dominik Andreas Barth, Felix Prinz, Julia Teppan, Katharina Jonas, Christiane Klec, Martin Pichler · 2020 · Non-Coding RNA
Recent advancements in PARP inhibitors-based targeted cancer therapy
Ping Zhou, Justin L. Wang, Daniel Mishail, Cun‐Yu Wang · 2020 · Precision Clinical Medicine
OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features
Zeng, Billy, Glicksberg, Benjamin S., Newbury, Patrick, Chekalin, Evgeny, Xing, Jing, Liu, Ke, Wen, Anita, Chow, Caven, Chen, Bin · 2021 · Nature Protocols
Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3
Xuejiao Leng, Jianfeng Wang, Na An, Xue Wang, Yile Sun, Zhiwei Chen · 2020 · Oncogene
Tilting MYC toward cancer cell death
Colleen T. Harrington, Elena Sotillo, Chi Van Dang, Andrei Thomas‐Tikhonenko · 2021 · Trends in cancer
New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Susu Yu, Xinyue Peng, Wenji Zhang, Wenjuan Zhang · 2022 · Frontiers in Pharmacology
ERK and c-Myc signaling in host-derived tumor endothelial cells is essential for solid tumor growth
Zehua Zuo, Jie Liu, Zhihao Sun, Yu‐Wei Cheng, Michael Ewing, Thomas Henrik Bugge, Toren Finkel, Stephen Howard Leppla, Shihui Liu · 2022 · Proceedings of the National Academy of Sciences
Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages
Luke A. Bourner, Linda A. Chung, Haiyan Long, Anne F. McGettrick, Junpeng Xiao, Kenneth D. W. Roth, Jade D. Bailey, Marie Strickland, Bo Tan, Jason Cunningham et al. · 2024 · Cell Reports
Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening
Zongxiang Zhou, Manishha Patel, Nicholas Ng, Mindy H. Hsieh, Anthony P. Orth, John R. Walker, Serge Batalov, Jennifer L Harris, Jun Liu · 2014 · BMC Cancer
Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia
Suzanne Schubbert, Anjelica M. Cardenas, Harrison Chen, Consuelo Garcia, Wei Guo, James E. Bradner, Hong Wu · 2014 · Cancer Research
Histone deacetylase inhibitor prevents cell growth in Burkitt’s lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101
Ana Carolina dos Santos Ferreira, Marcela Cristina Robaina, Lídia Maria Magalhães de Rezende, Patrícia Severino, Claudete Esteves Klumb · 2014 · Annals of Hematology
Cyclophilin B Supports Myc and Mutant p53-Dependent Survival of Glioblastoma Multiforme Cells
Jae Won Choi, Mark A. Schroeder, Jann Nagina Sarkaria, Richard J. Bram · 2013 · Cancer Research
Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature
Alejandro Vázquez‐Martín, Olga V. Anatskaya, Alessandro Giuliani, Jekaterina A. Erenpreisa, Sui Huang, Kristīne Salmiņa, Inna Inashkina, Anda Huna, Nikolay N. Nikolsky, Alexander E. Vinogradov · 2016 · Oncotarget
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
Benjamin L. Bryson, Damian J. Junk, Rocky Cipriano, Mark W. Jackson · 2016 · Cell Cycle
N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc
Yongfang Wang, You Zhou, Feng Tao, Shoujie Chai, Xia Xu, Ying Yang, Yiming Yang, Haiyan Xu, Kai Wang · 2017 · Cancer Letters
Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion
Yukiko Takeuchi, Yasumune Nakayama, Eiichiro Fukusaki, Yasuhiro Irino · 2017 · Biochemical and Biophysical Research Communications
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency–Mediated Acquired Resistance to Temozolomide
Fumi Higuchi, Alexandria L. Fink, Juri Kiyokawa, Julie J. Miller, Mara V.A. Koerner, Daniel P. Cahill, Hiroaki Wakimoto · 2018 · Molecular Cancer Therapeutics
c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma
Shangfeng Li, Shengkai Zhang, Jie Chen · 2019 · Cancer Gene Therapy
A Regulator of Metabolic Reprogramming: MicroRNA Let-7
Shuai Jiang · 2019 · Translational Oncology
RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers
Jiwei Zhang, Shengli Li, Ling Zhang, Juan Xu, Mingxu Song, Tingting Shao, Zhaohui Huang, Yongsheng Li · 2020 · Molecular Therapy
Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice
Yue Sheng, Rui Ma, Chunjie Yu, Qiong Wu, Steven Zhang, Kimberly Paulsen, Jiwang Zhang, Hongyu Ni, Yong Huang, Yi Zheng et al. · 2020 · Blood
Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling
Adrian Wullweber, Reiner Strick, Fabienne Lange, Danijel Sikic, Helge W. Taubert, Sven Wach, Bernd Wullich, Simone Bertz, Veronika Weyerer, Robert Stoehr et al. · 2021 · Cancer Research
Control of Vertebrate Development by MYC
Peter J. Hurlin · 2013 · Cold Spring Harbor Perspectives in Medicine
Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway
Lan, Yulong, Lou, Jiacheng, Hu, Jiliang, Yu, Zhikuan, Lyu, Wen, Zhang, Bo · 2020 · Cancer Biology and Medicine
Insights into Aflatoxin B1 Toxicity in Cattle: An In Vitro Whole-Transcriptomic Approach
Marianna Pauletto, Roberta Tolosi, Mery Giantin, Giorgia Guerra, Andrea Barbarossa, Anna Zaghini, Mauro Dacasto · 2020 · Toxins
MYCN and Metabolic Reprogramming in Neuroblastoma
Mohit Bansal, Anamika Gupta, Han‐Fei Ding · 2022 · Cancers
Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
Shuo Liu, Zhen Qin, Yaqing Mao, Wenbo Zhang, Yujia Wang, Lingfei Jia, Xin Peng · 2022 · OncoImmunology
Vitamin D in Cancer Prevention: Gaps in Current Knowledge and Room for Hope
Matthias Henn, Víctor Martín-Gorgojo, Jose Maria Martin-Moreno · 2022 · Nutrients
G4-Ligand-Conjugated Oligonucleotides Mediate Selective Binding and Stabilization of Individual G4 DNA Structures
Andreas Berner, Rabindra Nath Das, Naresh Bhuma, Justyna Golebiewska, Alva Abrahamsson, Måns Andréasson, Namrata Chaudhari, Mara Doimo, Partha Pratim Bose, Karam Chand et al. · 2024 · Journal of the American Chemical Society
Dual-role transcription factors stabilize intermediate expression levels
Jinnan He, Xiangru Huo, Gaofeng Pei, Zeran Jia, Yiming Yan, Jiawei Yu, Haozhi Qu, Yunxin Xie, Junsong Yuan, Yuan Zheng et al. · 2024 · Cell
Antitumor mechanisms when pRb and p53 are genetically inactivated
Liang Zhu, Zhonglei Lu, Heng-tai Zhao · 2014 · Oncogene
Henryin, an ent-kaurane Diterpenoid, Inhibits Wnt Signaling through Interference with β-Catenin/TCF4 Interaction in Colorectal Cancer Cells
Xingyao Li, Jian‐Xin Pu, Shi‐You Jiang, Jia Su, Lingmei Kong, Bingyu Mao, Han‐Dong Sun, Yan Li · 2013 · PLoS ONE
The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation
Junwen Shi, Wei Liu, Tingting Zhang, Shengchun Wang, Xiaolin Lin, Jing Li, Jun-Shuang Jia, Hong-Fen Sheng, Zhi-Fang Yao, Wentao Zhao et al. · 2013 · Cell Cycle
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group
Risa Niemas-Teshiba, Ryosuke Matsuno, Larry L. Wang, Xao X. Tang, Bill Chiu, Jasmine C. Zeki, Jeannine M. Coburn, Kimberly J. Ornell, Arlene H. Naranjo, Collin Van Ryn et al. · 2017 · Oncotarget
The c‐MYC–BMI1 axis is essential for SETDB1‐mediated breast tumourigenesis
Jin‐Fen Xiao, Qiao‐Yang Sun, Ling‐Wen Ding, Wenwen Chien, Xinyu Liu, Anand Mayakonda, Yan‐Yi Jiang, Xin-Yi Loh, Xue‐Bin Ran, Ngan Doan et al. · 2018 · The Journal of Pathology
Chronic Hexavalent Chromium Exposure Induces Cancer Stem Cell-Like Property and Tumorigenesis by Increasing c-Myc Expression
Zhishan Wang, Hsuan-Pei Lin, Yunfei Li, Hua Tao, Ping Yang, Jie Xie, Drew Maddy, Kazuya Kondo, Chengfeng Yang · 2019 · Toxicological Sciences
Subtle structural alterations in G-quadruplex DNA regulate site specificity of fluorescence light-up probes
Rajendra Kumar, Karam Chand, Sudipta Bhowmik, Rabindra Nath Das, Snehasish Bhattacharjee, Mattias Hedenström, Erik Chorell · 2019 · Nucleic Acids Research
Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer
Jiayang Wang, Weiguo Zhu, Guangzhou Tao, Wanwei Wang · 2020 · Bioengineered
The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity
Fengmei Cui, Rong Fan, Qiu Chen, Yong‐Ming He, Man Shu Song, Zeng‐Fu Shang, Shimeng Zhang, Wei Zhong Zhu, Jianping Cao, Hua Guan et al. · 2015 · Molecular and Cellular Biochemistry
Cellular MYCro Economics: Balancing MYC Function with MYC Expression
David Levens · 2013 · Cold Spring Harbor Perspectives in Medicine
Emerging tale of UPR and cancer: an essentiality for malignancy
Younis Hazari, Arif Bashir, Ehtisham Ul Haq, Khalid Majid Fazili · 2016 · Tumor Biology
Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis
Fabian Schuler, Johannes G. Weiss, Silke E. Lindner, Michael Lohmüller, Sebastian Herzog, Simon F. Spiegl, Philipp Menke, Stephan Geley, Verena Labi, Andreas Villunger · 2017 · Nature Communications
High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
Eriko Katsuta, Li Yan, Takashi Takeshita, Kerry-Ann McDonald, Subhamoy Dasgupta, Mateusz Opyrchal, Kazuaki Takabe · 2019 · International Journal of Molecular Sciences
Glutamine metabolism: from proliferating cells to cardiomyocytes
Yimin Shen, Yuhao Zhang, Wudi Li, Kaijie Chen, Meixiang Xiang, Hong Ma · 2021 · Metabolism
Acidosis Decreases c-Myc Oncogene Expression in Human Lymphoma Cells: A Role for the Proton-Sensing G Protein-Coupled Receptor TDAG8
Zhigang Li, Lixue Dong, Eric A. Dean, Li V. Yang · 2013 · International Journal of Molecular Sciences
NUCKS Is a Positive Transcriptional Regulator of Insulin Signaling
Beiying Qiu, Xiaohe Shi, Ee Tsin Wong, Joy Lim, Marco Bezzi, Diana Low, Qiling Zhou, Semih Can Akıncılar, Manikandan Lakshmanan, Hannah L. F. Swa et al. · 2014 · Cell Reports
Hyaluronic acid enhances proliferation of human amniotic mesenchymal stem cells through activation of Wnt/β-catenin signaling pathway
Ru‐Ming Liu, Ren-Gang Sun, Ling-Tao Zhang, Qingfang Zhang, Daixiong Chen, Jian‐Jiang Zhong, Jian‐Hui Xiao · 2016 · Experimental Cell Research
FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis
Xu Li, Wenqi Wang, Yuanxin Xi, Min Gao, My Kim Tran, Kathryn E. Aziz, Jun Qin, Wei Li, Junjie Chen · 2016 · Cell Reports
JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer
Haifeng Qiu, Jing Li, Leslie Horn Clark, Amanda Lynn Jackson, Lu Zhang, Hui Guo, Joshua E. Kilgore, Paola A. Gehrig, Chunxiao Zhou, Victoria Lin Bae-Jump · 2016 · Oncotarget · Retracted
Cell cycle-coupled expansion of AR activity promotes cancer progression
Christopher M. McNair, Alfonso Urbanucci, Clay E.S. Comstock, Michael A. Augello, Jonathan F. Goodwin, Rosalind Launchbury, Shuang George Zhao, Matthew Joseph Schiewer, Adam Ertel, Jeffrey R. Karnes et al. · 2016 · Oncogene
Multiple Roles of MYC in Integrating Regulatory Networks of Pluripotent Stem Cells
Luca Fagnocchi, Alessio Zippo · 2017 · Frontiers in Cell and Developmental Biology
TIMELESS contributes to the progression of breast cancer through activation of MYC
Limin Chi, Yujiao Zou, Ling Qin, Weifeng Ma, Yanyan Hao, Yaoliang Tang, Rongcheng Luo, Ziqing Wu · 2017 · Breast Cancer Research
Aberrant Wnt signaling: a special focus in CNS diseases
Mercedes Arnés, Sergio Casas‐Tintó · 2017 · Journal of Neurogenetics
Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction
Yuqing Wang, Zhou-Li Huang, Shuo-Bin Chen, Chenxi Wang, Chan Shan, Qikun Yin, Tian-Miao Ou, Ding Li, Lian-Quan Gu, Jia‐Heng Tan et al. · 2017 · Journal of Medicinal Chemistry
MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells
Luciano Mazzoccoli, Marcela Cristina Robaina, Alexandre Gustavo Apa, Martín Bonamino, Luciana Wernersbach Pinto, Eduardo Queiroga, Carlos E. Bacchi, Claudete Esteves Klumb · 2018 · Journal of Cancer Research and Clinical Oncology
Targeting FBPase is an emerging novel approach for cancer therapy
Gao‐Min Liu, Yao-Ming Zhang · 2018 · Cancer Cell International
Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc
Jingyi Zhang, Pengwei Ren, Da Xu, Xiaofeng Liu, Zhenzhen Liu, Chunfeng Zhang, Yuan Li, Lijun Wang, Xiaojuan Du, Baocai Xing · 2018 · Cancer Letters
Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status
Davood Bashash, Mohammad Sayyadi, Ava Safaroghli‐Azar, Negar Sheikh‐Zeineddini, Niknam Riyahi, Majid Momeny · 2019 · The International Journal of Biochemistry & Cell Biology
PRMT7 promotes the growth of renal cell carcinoma through modulating the β-catenin/C-MYC axis
Fei Liu, Lisong Wan, Haibin Zou, Zhengyue Pan, Wanming Zhou, Xiongbing Lu · 2020 · The International Journal of Biochemistry & Cell Biology
Saturated Oxo Fatty Acids (SOFAs): A Previously Unrecognized Class of Endogenous Bioactive Lipids Exhibiting a Cell Growth Inhibitory Activity
Charikleia S. Batsika, Christiana Mantzourani, Dimitrios Gkikas, Maroula G. Kokotou, Olga G. Mountanea, Christoforos G. Kokotos, Panagiotis K. Politis, George Kokotos · 2021 · Journal of Medicinal Chemistry
High-throughput screening of salivary polyamine markers for discrimination of colorectal cancer by multisegment injection capillary electrophoresis tandem mass spectrometry
Kaori Igarashi, Sana Ota, Miku Kaneko, Akiyoshi Hirayama, Masanobu Enomoto, Kenji Katumata, Masahiro Sugimoto, Tomoyoshi Soga · 2021 · Journal of Chromatography A
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis
Yiwu Yan, Bo O. Zhou, Qian Chen, Alex Vasquez, Mohini Kamra, Avradip Chatterjee, Yeon‐Joo Lee, Xiaopu Yuan, Leigh Ellis, Dolores Di Vizio et al. · 2022 · Nature Communications
Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
Haixiang Pei, Weikai Guo, Yangrui Peng, Hai Xiong, Yihua Chen · 2022 · Medicinal Research Reviews
Co-occurrence of MYC amplification and TP53 mutations in human cancer
Peter Ulz, Ellen Heitzer, Michael R. Speicher · 2016 · Nature Genetics
Asbestos conceives Fe(II)-dependent mutagenic stromal milieu through ceaseless macrophage ferroptosis and β-catenin induction in mesothelium
Ito, Fumiya, Yanatori, Izumi, Maeda, Yuki, Nimura, Kenta, Ito, Satoki, Hirayama, Tasuku, Nagasawa, Hideko, Kohyama, Norihiko, Okazaki, Yasumasa, Akatsuka, Shinya et al. · 2020 · Redox Biology
c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
Caggiano, Cinzia, Pieraccioli, Marco, Panzeri, Valentina, Sette, Claudio, Bielli, Pamela · 2019 · Nucleic Acids Research